Epirubicin Hydrochloride (DBL)
What it is used for
Epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic disease. DBL Epirubicin Hydrochloride Injection and DBL Epirubicin Hydrochloride for Injection are indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-Hodgkin’s lymphoma), advanced/metastatic soft tissue sarcoma and superficial bladder cancer (Tis; Ta). In bladder cancer, DBL Epirubicin Hydrochloride Injection and DBL Epirubicin Hydrochloride for Injection are also indicated in the prophylaxis of recurrence after transurethral resection of T1 papillary cancers and stage Ta multifocal papillary cancers (Grade 2 and 3).
How to take it
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Pregnant or planning a pregnancy?
For the active ingredient epirubicin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Visual appearance
A clear, red solution free from visible particulates.